Chinese Society of Biotechnology

会员登录 会员注册
About the CBC

The 16th CBC

Period:September 19-21, 2024

Location: Guangzhou

Theme: Building a New Bio-Manufacturing Industry and Pioneering New Tracks in Life Sciences

Overview:

The 16th China Bio-Industry Convention was successfully held in Guangzhou from September 19 to 21, 2024.

Under the theme "Building a New Bio-Manufacturing Industry and Pioneering New Tracks in Life Sciences," the convention hosted 26 events, including the Bio-Manufacturing High-Level Forum, 10 specialized sub-forums, the Bio-Manufacturing Innovation and Entrepreneurship Competition, supply-demand matchmaking sessions, a national bio-industry base development on-site meeting, the Guangzhou Bio-Medical and High-End Medical Equipment Industry Chain "Chain Leader Meeting," industry policy and innovation achievements exhibitions, and the Life and Health Carnival. The conference attracted nearly 20,000 on-site participants and over 5 million online attendees.

The event invited 10 domestic and international academicians, over 40 national association leaders, and more than 150 bio-industry experts and leading entrepreneurs from both China and abroad. They gathered to exchange ideas on technological innovations and industry development in the fields of bio-medicine, bio-manufacturing, and bio-information, and discussed strategies for promoting the high-quality development of the bio-industry. The exhibition area of the conference covered approximately 10,000 square meters, with over 150 exhibiting organizations. On-site transactions exceeded 10 million yuan.

For the first time, the Bio-Industry Competition was held, with 20 winning projects, attracting over 100 million USD in total investment and financing. This drew numerous investment institutions from both within and outside the province for cooperation discussions. More than 50 media outlets, both domestic and international, reported on the conference. As of September 22, the conference had been shared more than 3,000 times online, with a total viewership exceeding 1 million, achieving remarkable publicity results.